ILK and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, an emerging role for ILK-mediated signalling is especially promising in chronic myeloid leukemia (CML), a disease caused by the constitutively active tyrosine kinase BCR-ABL.